Literature DB >> 8850356

Clinical and physiological investigations in patients with taste abnormality.

T Osaki1, M Ohshima, Y Tomita, N Matsugi, Y Nomura.   

Abstract

The cause of taste abnormality was investigated in 25 patients with decreased taste sensation (hypogeusia group) and 14 patients with abnormal taste sensation (dysgeusia group) by examining taste threshold, salivary flow rate, Candida cell culture, and laboratory examination of peripheral blood. The cause of hypogeusia was identified as iron deficiency in 7 patients, oral candidiasis in 6, hyposalivation (xerostomia) in 6, and psychiatric distress in 3, and could not be determined in 3 (idiopathic). Dysgeusia was associated with psychiatric distress in 8 patients, oral candidiasis in 3, drug medication in 2, and hyposalivation in 1. In the hypogeusia group, the decreased taste sensation generally corresponded with elevated taste thresholds, which decreased along with improvement of the decreased taste sensation in all except the 3 patients with psychiatric etiology and 2 of the 3 patients with idiopathic etiology. In contrast, no elevation or depression of taste thresholds were observed in the dysgeusia group, and the abnormal taste sensation did not disappear in most cases; however, drug-induced dysgeusia improved completely within 2 months after cessation of the drug administration. The serum copper and zinc levels were not decreased in any patient, but a decreased serum iron level was observed in 7 patients. Based on these results, it is concluded that abnormal taste sensation may be induced by many oral and systemic disturbances and that hypogeusia, which may be induced by deficiency of iron but not of zinc or copper, is usually accompanied by elevation of taste thresholds, while dysgeusia is not.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8850356     DOI: 10.1111/j.1600-0714.1996.tb01221.x

Source DB:  PubMed          Journal:  J Oral Pathol Med        ISSN: 0904-2512            Impact factor:   4.253


  5 in total

1.  Dysgeusia related to urinary obstruction from benign prostatic disease: a case control and qualitative study.

Authors:  R K Mal; M A Birchall
Journal:  Eur Arch Otorhinolaryngol       Date:  2006-02       Impact factor: 2.503

2.  Xerostomia and medications among 32-year-olds.

Authors:  William Murray Thomson; Richie Poulton; Jonathan Mark Broadbent; Shaima Al-Kubaisy
Journal:  Acta Odontol Scand       Date:  2006-08       Impact factor: 2.331

Review 3.  The Influence of Viral Infections on Iron Homeostasis and the Potential for Lactoferrin as a Therapeutic in the Age of the SARS-CoV-2 Pandemic.

Authors:  Jeffrey L Ward; Moises Torres-Gonzalez; Mary Cloud B Ammons
Journal:  Nutrients       Date:  2022-07-27       Impact factor: 6.706

Review 4.  Glutathione Supplementation as an Adjunctive Therapy in COVID-19.

Authors:  Vika Guloyan; Buzand Oganesian; Nicole Baghdasaryan; Christopher Yeh; Manpreet Singh; Frederick Guilford; Yu-Sam Ting; Vishwanath Venketaraman
Journal:  Antioxidants (Basel)       Date:  2020-09-25

5.  COVID-19 spreading across world correlates with C677T allele of the methylenetetrahydrofolate reductase (MTHFR) gene prevalence.

Authors:  Giovanni Ponti; Lorenza Pastorino; Marco Manfredini; Tomris Ozben; Gabriella Oliva; Shaniko Kaleci; Raffaele Iannella; Aldo Tomasi
Journal:  J Clin Lab Anal       Date:  2021-06-01       Impact factor: 3.124

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.